Chiome Bioscience Inc. reported non-consolidated financial results for the year ended Dec. 31, 2017. For the year, the company reported operating loss of ¥887 million and net loss of ¥882 million or ¥33.48 per share on net sales of ¥259 million against operating loss of ¥1,047 million and net loss of ¥1,491 million or ¥65.91 per share on net sales of ¥252 million for the last year. Negative ROE was 20.3% against 32.9% for the last year. Cash Flow from operating activities was ¥867 million against ¥969 million for the last year. Loss before income taxes was ¥880 million against ¥1,501.3 million for the last year. Purchase of property and equipment was ¥4.975 million against ¥10.455 million for the last year. Purchase of intangible assets was ¥500,000.